Cargando…

Selective Estrogen Receptor β Agonist LY500307 as a Novel Therapeutic Agent for Glioblastoma

Glioblastomas (GBM), deadly brain tumors, have greater incidence in males than females. Epidemiological evidence supports a tumor suppressive role of estrogen; however, estrogen as a potential therapy for GBM is limited due to safety concerns. Since GBM express ERβ, a second receptor for estrogen, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sareddy, Gangadhara R., Li, Xiaonan, Liu, Jinyou, Viswanadhapalli, Suryavathi, Garcia, Lauren, Gruslova, Aleksandra, Cavazos, David, Garcia, Mike, Strom, Anders M., Gustafsson, Jan-Ake, Tekmal, Rajeshwar Rao, Brenner, Andrew, Vadlamudi, Ratna K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4850367/ https://www.ncbi.nlm.nih.gov/pubmed/27126081 http://dx.doi.org/10.1038/srep24185

Ejemplares similares

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer
por: Liu, Jinyou, et al.
Publicado: (2017)

Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways
por: Zhou, Mei, et al.
Publicado: (2019)

Histone deacetylase inhibitors enhance estrogen receptor beta expression and augment agonist-mediated tumor suppression in glioblastoma
por: Pratap, Uday P, et al.
Publicado: (2021)

Brain-Derived Estrogen and Neurological Disorders
por: Brann, Darrell W., et al.
Publicado: (2022)

Neuron-Derived Estrogen—A Key Neuromodulator in Synaptic Function and Memory
por: Brann, Darrell W., et al.
Publicado: (2021)

Brain-derived estrogen and neural function
por: Brann, Darrell W., et al.
Publicado: (2022)

Estrogen receptor coregulator binding modulators (ERXs) effectively target estrogen receptor positive human breast cancers
por: Raj, Ganesh V, et al.
Publicado: (2017)

Neuron-Derived Estrogen Is Critical for Astrocyte Activation and Neuroprotection of the Ischemic Brain
por: Lu, Yujiao, et al.
Publicado: (2020)

SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance
por: Liu, Zexuan, et al.
Publicado: (2022)

Estrogen receptor coregulator binding modulator (ERX-11) enhances the activity of CDK4/6 inhibitors against estrogen receptor-positive breast cancers
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2019)

Different Susceptibilities of Human Melanoma Cell Lines to G2/M Blockage and Cell Death Activation in Response to the Estrogen Receptor β agonist LY500307
por: Pontecorvi, Giada, et al.
Publicado: (2022)

Global Genomic and Proteomic Analysis Identified Critical Pathways Modulated by Proto-Oncogene PELP1 in TNBC
por: Liu, Zexuan, et al.
Publicado: (2022)

Development and Characterization of Inducible Astrocyte-Specific Aromatase Knockout Mice
por: Wang, Jing, et al.
Publicado: (2023)

Therapeutic Targeting of Ovarian Cancer Stem Cells Using Estrogen Receptor Beta Agonist
por: He, Yi, et al.
Publicado: (2022)

Inhibition of LIFR Blocks Adiposity-Driven Endometrioid Endometrial Cancer Growth
por: Blankenship, Logan, et al.
Publicado: (2022)

Interaction of transcription factor AP‐2 gamma with proto‐oncogene PELP1 promotes tumorigenesis by enhancing RET signaling
por: Liu, Junhao, et al.
Publicado: (2021)

LIF/LIFR oncogenic signaling is a novel therapeutic target in endometrial cancer
por: Tang, Weiwei, et al.
Publicado: (2021)

PELP1 promotes glioblastoma progression by enhancing Wnt/β-catenin signaling
por: Sareddy, Gangadhara R, et al.
Publicado: (2019)

2114: The role of estrogen receptor-β in the development of the early endometriotic lesion
por: Knudtson, Jennifer, et al.
Publicado: (2018)

Targeting PELP1 oncogenic signaling in TNBC with the small molecule inhibitor SMIP34
por: Altwegg, Kristin A., et al.
Publicado: (2023)

Neuron-Derived Estrogen Regulates Synaptic Plasticity and Memory
por: Lu, Yujiao, et al.
Publicado: (2019)

LIFR inhibition enhances the therapeutic efficacy of HDAC inhibitors in triple negative breast cancer
por: Li, Mengxing, et al.
Publicado: (2021)

The antidepressant imipramine inhibits breast cancer growth by targeting estrogen receptor signaling and DNA repair events
por: Timilsina, Santosh, et al.
Publicado: (2022)

Roscovitine confers tumor suppressive effect on therapy-resistant breast tumor cells
por: Nair, Binoj C, et al.
Publicado: (2011)

Targeting LIF/LIFR signaling in cancer
por: Viswanadhapalli, Suryavathi, et al.
Publicado: (2021)

Regulation of rDNA Transcription by Proto-Oncogene PELP1
por: Gonugunta, Vijay K., et al.
Publicado: (2011)

NLRP3 Inflammasome Activation in the Brain after Global Cerebral Ischemia and Regulation by 17β-Estradiol
por: Thakkar, Roshni, et al.
Publicado: (2016)

Targeting LIPA independent of its lipase activity is a therapeutic strategy in solid tumors via induction of endoplasmic reticulum stress
por: Liu, Xihui, et al.
Publicado: (2022)

301 Inhibition of lysine-specific histone demethylase 1A (KDM1A/LSD1) attenuates DNA double strand break repair and enhances efficacy of temozolomide in glioblastoma
por: Alejo, Salvador, et al.
Publicado: (2023)

Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
por: Alonso-Magdalena, Paloma, et al.
Publicado: (2013)

Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
por: Gupta, Harshita B, et al.
Publicado: (2016)

KDM1 is a novel therapeutic target for the treatment of gliomas
por: Sareddy, Gangadhara R., et al.
Publicado: (2012)

Role of Estrogen Receptor Signaling in Breast Cancer Metastasis
por: Saha Roy, Sudipa, et al.
Publicado: (2012)

Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer
por: Roy, Sudipa Saha, et al.
Publicado: (2013)

Role of estrogen receptor coregulators in endocrine resistant breast cancer
por: Altwegg, Kristin A., et al.
Publicado: (2021)

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway
por: Bowers, Laura W., et al.
Publicado: (2015)

Regulation and Role of Neuron-Derived Hemoglobin in the Mouse Hippocampus
por: Lu, Yujiao, et al.
Publicado: (2022)

EC330, a small-molecule compound, is a potential novel inhibitor of LIF signaling
por: Yue, Xuetian, et al.
Publicado: (2020)

Epigenetics of Estrogen Receptor Signaling: Role in Hormonal Cancer Progression and Therapy
por: Mann, Monica, et al.
Publicado: (2011)

Aromatase Expression Increases the Survival and Malignancy of Estrogen Receptor Positive Breast Cancer Cells
por: Mukhopadhyay, Keya De, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_lerj9mmpbgfb1ndmcklku3jkcs